Public healthfromwww.mercurynews.com5 days agoCalifornia' brand insulin is hitting the marketCalifornia will sell state-manufactured CalRx insulin for $55 per month and cap insurance insulin costs at $35 monthly.
fromwww.scientificamerican.com6 days agoScienceNew Cell Transplant Therapy Restores Insulin Production in Patient with Type 1 Diabetes
fromwww.scientificamerican.com1 month agoPublic healthHow Long Can People Survive with Type 1 Diabetes? It Depends on Where They Live
fromwww.scientificamerican.com2 months agoMedicineThe 2,000-Year Journey to Understanding Type 1 DiabetesAnd What's Next
fromwww.scientificamerican.com2 months agoMedicineA New Drug Slows the Worsening of Type 1 Diabetes and Has Sped up Work on a Full Cure
fromwww.scientificamerican.com6 days agoScienceNew Cell Transplant Therapy Restores Insulin Production in Patient with Type 1 Diabetes
fromwww.scientificamerican.com1 month agoPublic healthHow Long Can People Survive with Type 1 Diabetes? It Depends on Where They Live
fromwww.scientificamerican.com2 months agoMedicineThe 2,000-Year Journey to Understanding Type 1 DiabetesAnd What's Next
fromwww.scientificamerican.com2 months agoMedicineA New Drug Slows the Worsening of Type 1 Diabetes and Has Sped up Work on a Full Cure
fromIrish Independent2 months agoCan Type 2 diabetes be put into remission? - Dr Sean Maher addresses the questionRoughly there's about 300,000 people living with diabetes in Ireland and 90% of that is type two diabetes. And about 10% will be type one.Medicine
MedicinefromWIRED3 months agoCrispr Offers New Hope for Treating DiabetesCrispr-Cas12b–edited hypoimmune pancreatic islet cells produced insulin for months in a man with type 1 diabetes without immunosuppressive drugs.
fromNature3 months agoMedicineHope for diabetes: CRISPR-edited cells pump out insulin in a person - and evade immune detection
fromNature3 months agoMedicineHope for diabetes: CRISPR-edited cells pump out insulin in a person - and evade immune detection
fromSFGATE3 months agoNew York CityHoda Kotb Reveals New Routine in the Suburbs After Leaving 'Today'-What You Need to Know
fromSFGATE6 months agoParentingHoda Kotb Reveals Truth About Daughter Hope's Medical Condition-and How It Pushed Her To Quit 'Today' and Move to Suburbs
fromPage Six6 months agoParentingHoda Kotb finally reveals daughter Hope's mysterious health diagnosisHoda Kotb steps back from NBC News to prioritize health for her daughter diagnosed with Type 1 diabetes.
fromNew York Post6 months agoParentingHoda Kotb reveals the heartbreaking reason why she really left 'Today'Hoda Kotb left 'Today' to prioritize her daughter Hope, who has Type 1 diabetes.
fromSFGATE3 months agoNew York CityHoda Kotb Reveals New Routine in the Suburbs After Leaving 'Today'-What You Need to Know
ParentingfromSFGATE6 months agoHoda Kotb Reveals Truth About Daughter Hope's Medical Condition-and How It Pushed Her To Quit 'Today' and Move to SuburbsHoda Kotb's emotional return to 'Today' reveals her daughter Hope's Type 1 diabetes diagnosis, impacting her career decisions and family priorities.
ParentingfromPage Six6 months agoHoda Kotb finally reveals daughter Hope's mysterious health diagnosisHoda Kotb steps back from NBC News to prioritize health for her daughter diagnosed with Type 1 diabetes.
ParentingfromNew York Post6 months agoHoda Kotb reveals the heartbreaking reason why she really left 'Today'Hoda Kotb left 'Today' to prioritize her daughter Hope, who has Type 1 diabetes.
fromFast Company5 months agoWomenMattel's type 1 diabetes Barbie doll wears an insulin pump and glucose monitor. Here's her origin story
fromFast Company5 months agoWomenMattel's type 1 diabetes Barbie doll wears an insulin pump and glucose monitor. Here's her origin story
Womenfromwww.theguardian.com5 months agoRepresentation matters': Barbie launches first doll with type 1 diabetesBarbie's new doll represents children with type 1 diabetes, featuring essential medical tools for managing the condition.
fromBoston.com6 months agoBoston drug company laying off 125 employees in R.I.Business Vertex says the layoffs are due to the discontinuation of a Type 1 diabetes study.NYC startup